Medicare Enrolled
Dr. Angel De La Cruz, MD
Internal Medicine · Clifton, NJ
Practice pattern: Clinical Cardiology
— Primarily office-based clinical cardiology
Low-engagement
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. De La Cruz from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. De La Cruz?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. De La Cruz
Dr. Angel De La Cruz is an internal medicine specialist in Clifton, NJ, with 15 years of NPI registration. Based on federal Medicare data, Dr. De La Cruz performed 1,032 Medicare services across 658 unique beneficiaries.
Between the years covered by Open Payments, Dr. De La Cruz received a total of $20,969 from 56 pharmaceutical and/or device companies across 821 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in internal medicine. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. De La Cruz is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 15 years in practice
▲ Top 45% volume in NJ
$20,969 industry payments
Medicare Practice Summary
Medicare Utilization ↗1,032
Medicare services
Top 45% in NJ for internal medicine
658
Unique beneficiaries
$59
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~69 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
382 | $66 | $105 |
| Chronic care management, first 20 min/month This service covers the first 20 minutes of clinical staff time directed by a healthcare professional each calendar month to manage chronic conditions. |
93 | $44 | $69 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
85 | $91 | $141 |
| Ultrasound of arm and leg arteries This procedure uses sound waves to create images of the blood vessels in the arms and legs. It allows healthcare providers to examine the structure and blood flow within these arteries. |
83 | $60 | $103 |
| Drug injection, under skin or into muscle A procedure involving the administration of a medication or substance via injection into the subcutaneous tissue or muscle. |
75 | $10 | $20 |
| Annual wellness visit, follow-up A follow-up annual wellness visit that includes a personalized prevention plan of service. |
66 | $139 | $153 |
| Vitamin B-12 injection An injection of vitamin B-12 (cyanocobalamin) with a dose of up to 1000 mcg. |
51 | $1 | $50 |
| Quadrivalent influenza vaccine, cell culture-derived A flu shot that protects against four strains of the influenza virus. It is produced using cell culture technology rather than traditional egg-based methods. |
30 | $32 | $75 |
| Electrocardiogram (EKG), 12-lead A standard heart rhythm test using at least 12 leads to record electrical activity. A healthcare provider interprets the results and provides a written report. |
27 | $11 | $17 |
| Continuous glucose monitoring, sensor under skin This procedure involves continuous monitoring of blood sugar levels in tissue fluid using a sensor placed under the skin with provider-supplied equipment. |
26 | $120 | $192 |
| Continuous glucose monitoring with interpretation This procedure involves monitoring blood sugar levels in tissue fluid using a sensor placed under the skin, along with the interpretation and reporting of the results. |
26 | $29 | $41 |
| Flu vaccine administration This procedure involves the administration of the influenza virus vaccine. It covers the process of delivering the vaccine to the patient. |
26 | $34 | $50 |
| New patient office visit (30-44 min) An initial office visit for a new patient lasting between 30 and 44 minutes. This code is used when the total time spent on the date of the encounter falls within this range. |
14 | $71 | $123 |
| Spirometry test before and after medication A test that measures the amount of air you can exhale and the speed of your breathing before and after taking a medication. |
12 | $32 | $55 |
| Lung volume test using sensors A test that measures the amount of air in the lungs using sensors. |
12 | $39 | $70 |
| Pulmonary gas exchange test A test to examine how well the lungs exchange gases. |
12 | $39 | $73 |
| Telephone medical discussion, 11-20 minutes A phone conversation with a physician lasting between 11 and 20 minutes. |
12 | $64 | $99 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
Industry Payment Transparency
Open Payments through 2024 ↗$20,969
Total received (2018-2024)
Avg $2,996/year across 7 years
Top 3% in NJ for internal medicine
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
56
Companies
821
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$20,969 (100.0%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$3,264
2023
$3,386
2022
$3,785
2021
$4,236
2020
$2,612
2019
$2,534
2018
$1,152
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
AstraZeneca Pharmaceuticals LP
$1,076
Amgen Inc.
$387
Boehringer Ingelheim Pharmaceuticals, Inc.
$384
GlaxoSmithKline, LLC.
$201
Novo Nordisk Inc
$172
ABBVIE INC.
$136
Hologic Sales and Service, LLC
$135
Inari Medical, Inc.
$132
Exact Sciences Corporation
$104
Novartis Pharmaceuticals Corporation
$88
IRONWOOD PHARMACEUTICALS, INC
$75
Salix Pharmaceuticals, a division of Bausch Health US, LLC
$49
Ardelyx, Inc.
$46
SHIELD THERAPEUTICS INC
$41
Xeris Pharmaceuticals, Inc.
$35
Lilly USA, LLC
$34
AERIN MEDICAL INC.
$33
Merck Sharp & Dohme LLC
$32
Otsuka America Pharmaceutical, Inc.
$31
Phathom Pharmaceuticals, Inc.
$29
Currax Pharmaceuticals LLC
$16
Astellas Pharma US Inc
$15
Bayer Healthcare Pharmaceuticals Inc.
$13
Top 3 companies account for 56.6% of 2024 payments
All-time payments by company (2018-2024) ›
Boehringer Ingelheim Pharmaceuticals, Inc.
$4,930
AstraZeneca Pharmaceuticals LP
$2,616
Novo Nordisk Inc
$1,880
Amgen Inc.
$1,654
GlaxoSmithKline, LLC.
$1,080
SANOFI-AVENTIS U.S. LLC
$751
Bayer HealthCare Pharmaceuticals Inc.
$630
AbbVie Inc.
$603
Lilly USA, LLC
$570
ABBVIE INC.
$497
Amarin Pharma Inc.
$477
Salix Pharmaceuticals, a division of Bausch Health US, LLC
$402
Merck Sharp & Dohme Corporation
$373
Bayer Healthcare Pharmaceuticals Inc.
$292
Abbott Laboratories
$265
Qiagen, LLC
$228
Mannkind Corporation
$225
Ironwood Pharmaceuticals, Inc
$211
Ardelyx, Inc.
$207
IRONWOOD PHARMACEUTICALS, INC
$194
Biohaven Pharmaceutical Holding Company Ltd.
$178
Merck Sharp & Dohme LLC
$171
Tepha Inc
$157
Kowa Pharmaceuticals America, Inc.
$155
Allergan, Inc.
$155
Allergan Inc.
$150
CVRx, Inc.
$149
QIAGEN, LLC
$142
MannKind Corporation
$140
Biogen, Inc.
$136
Hologic Sales and Service, LLC
$135
Inari Medical, Inc.
$132
PFIZER INC.
$125
Exact Sciences Corporation
$123
Novartis Pharmaceuticals Corporation
$121
E.R. Squibb & Sons, L.L.C.
$100
Astellas Pharma US Inc
$82
Janssen Pharmaceuticals, Inc
$58
Horizon Therapeutics plc
$55
Otsuka America Pharmaceutical, Inc.
$45
SHIELD THERAPEUTICS INC
$41
Xeris Pharmaceuticals, Inc.
$35
AERIN MEDICAL INC.
$33
Smith & Nephew, Inc.
$32
Amneal Pharmaceuticals LLC
$31
Phathom Pharmaceuticals, Inc.
$29
SUN PHARMACEUTICAL INDUSTRIES INC.
$29
ARBOR PHARMACEUTICALS, INC.
$27
Sumitomo Pharma America, Inc.
$18
Currax Pharmaceuticals LLC
$16
Smith+Nephew, Inc.
$16
Evoke Pharma, Inc.
$15
VistaPharm, Inc.
$15
Medtronic MiniMed, Inc.
$13
AbbVie, Inc.
$12
Alexion Pharmaceuticals, Inc.
$12
Top 3 companies account for 45.0% of all-time payments
Associated products mentioned in payments ›
ACCRUFER · ADUHELM · AFREZZA · AIRSUPRA · ANDEXXA · ANORO · ANORO ELLIPTA · APTIMA · AREXVY · Aimovig · Assurity Pacemaker · BASAGLAR · BELSOMRA · BREATHTEK · BREZTRI · BREZTRI AEROSPHERE · BYSTOLIC · Barostim Neo System · CARDIOMEMS · CHANTIX · COLOGUARD DNA CAPTURE REAGENTS · CONFIRM RX · CONTRAVE · CREON · Cologuard Collection Kit · DUEXIS · ELIQUIS · ENTRESTO · EVENITY · Edarbi · FARXIGA · FASENRA · FLOWTRIEVER CATHETER · FREESTYLE LIBRE 2 · FreeStyle Libre 2 · GARDASIL · GARDASIL 9 · GEMTESA · GIMOTI · GVOKE HYPOPEN · GalaFLEX · HUMIRA · Humira · IBSRELA · INVOKANA · JANUVIA · JARDIANCE · KAPSPARGO · KRYSTEXXA · Kerendia · LEQVIO · LINZESS · LO LOESTRIN FE · LOKELMA · LYVISPAH · Linzess · Livalo · MDX QUANTIFERON · MOUNJARO · MYRBETRIQ · Minimed 530G · Myrbetriq · NURTEC ODT · OFEV · Otezla · Ozempic · PNEUMOVAX 23 · PRADAXA · PREVNAR 20 · Prolia · QULIPTA · REXULTI · RINVOQ · RYBELSUS · Repatha · Rybelsus · S · SEGLENTIS · SKYRIZI · SOLIQUA · SOLIQUA 100/33 · SPIRIVA RESPIMAT · STIOLTO RESPIMAT · SYMBICORT · Santyl · Strensiq · THORATEC HEARTMATE 3 LVAS IMPLANT KIT · TOUJEO · TRADJENTA · TRELEGY ELLIPTA · TRULANCE · TRULICITY · Thyquidity · Tresiba · UBRELVY · VERQUVO · VESICARE · VIVAER STYLUS · VOQUEZNA · VRAYLAR · Vascepa · Veozah · Victoza · XARELTO · XIFAXAN
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Most payments (100%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians. Total industry engagement is in the top 3% for internal medicine in NJ.
Geographic Context
Internal medicine physicians within 10 mi
10,573
Per 100K population
2040.0
County median income
$87,137
Nearest hospital
ST JOSEPH'S UNIVERSITY MEDICAL CENTER INC
1.3 mi
1.3 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. De La Cruz is a clinical cardiology specialist, with moderate Medicare volume, with low-engagement industry engagement in the top 3% of NJ peers, with 15 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. De La Cruz experienced with office visit, established patient (20-29 min)?
Based on Medicare claims data, Dr. De La Cruz performed 382 office visit, established patient (20-29 min) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. De La Cruz receive payments from pharmaceutical companies?
Yes. Dr. De La Cruz received a total of $20,969 from 56 companies across 821 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. De La Cruz's costs compare to other internal medicine physicians in Clifton?
Dr. De La Cruz's average Medicare payment per service is $59. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. De La Cruz) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Same specialty & city
Internal Medicine Physicians in Clifton
Browse internal medicine physicians in Clifton ranked by procedure volume and transparency data.
Highest volume
Top Internal Medicine Physicians in NJ
Internal medicine physicians ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Internal Medicine Physicians in NJ
Which NJ internal medicine physicians receive the most from drug and device companies.
By company
Boehringer Ingelheim Pharmaceuticals, Inc. Payments to Doctors
See all physicians who received payments from Boehringer Ingelheim Pharmaceuticals, Inc.
By company
AstraZeneca Pharmaceuticals LP Payments to Doctors
See all physicians who received payments from AstraZeneca Pharmaceuticals LP.
By company
Novo Nordisk Inc Payments to Doctors
See all physicians who received payments from Novo Nordisk Inc.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology